PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova

Part of paid clinical trials in Falls Church, Virginia.

Sponsor
Inova Health Care Services
Study ID
NCT05433220
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Best Practice Advisory using Electronic Health Record — OTHER
    Providers caring for patients randomized to the intervention arm will have a best practice alert appear for each of their eligible patients upon opening of the order entry screen in the patient's medical record. This alert informs the provider to the presence of HFrEF, notes the patient's current LVEF and current evidence-based medications, and gives access to an order set with recommended evidence- based, guideline-recommended, and FDA- approved therapies for patients with HFrEF. Providers will also have access to a link to best available guideline recommended information regarding treatment of heart failure to allow further education if desired by the provider. The alerts will also clearly state the expected monitoring and follow-up required for prescriptions of these medications.

Study Details

A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fraction. This will be done across outpatient Inova clinics and at the five Inova hospitals.

Key Dates

Start date
Aug 25, 2022
Status verified
Aug 2025
Primary completion
Jun 30, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
5,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Alert when provider is entering orders
  • No Intervention: No alert, usual care

Primary Outcome Measure

Increased use of GDMT in patients with Heart Failure with Reduced Ejection Fraction [ Time Frame: 30 days after randomization ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Inova Health SystemFalls ChurchVirginia22042
Matthew Dimond
703-776-6248
Bhruga Shah
7037762828

Find similar trials in Falls Church, VA

By condition

Related Studies